David M. Nanus, M.D., medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, spoke to OncLive about treatment for patients with early-stage kidney cancer. Therapies that are showing progress in the advanced setting, such as immunotherapy, may have a place in early-stage cancer, says Nanus.
In another interview, Dr. Nanus discussed cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).
There have been a number of retrospective analyses comparing patients who have had a cytoreductive nephrectomy versus those who did not, explains Nanus. It was clear that patients who had a cytoreductive nephrectomy experienced a higher response.
According to Nanus, if a person can undergo a cytoreductive nephrectomy they should have one as the procedure is associated with improved survival.